Considering the effects of some fermentation products on intestinal morphology and finction, these variations may be relevant to the pathogenesis of colorectal diseases.
Abstract
Background/Aims-To investigate whether transit time could influence H2 consuming flora and certain indices of colonic bacterial fermentation. Methods-Eight healthy volunteers (four methane excretors and four non-methane excretors) were studied for three, three week periods during which they received a controlled diet alone (control period), and then the same diet with cisapride or loperamide. At the end of each period, mean transit time (MTT) was estimated, an H2 lactulose breath test was performed, and stools were analysed. Results-In the control period, transit time was inversely related to faecal weight, sulphate reducing bacteria counts, concentrations oftotal short chain fatty acids (SCFAs), propionic and butyric acids, and H2 excreted in breath after lactulose ingestion. Conversely, transit time was positively related to faecal pH and tended to be related to methanogen counts. Methanogenic bacteria counts were inversely related to those of sulphate reducing bacteria and methane excretors had slower MTT and lower sulphate reducing bacteria counts than non-methane excretors. Compared with the control period, MTT was significantly shortened (p<0.05) by cisapride and prolonged (p<005) by loperamide (73 (11) hours, 47 (5) hours and 147 (12) hours for control, cisapride, and loperamide, respectively, mean (SD)). Cisapride reduced transit time was associated with (a) a significant rise in faecal weight, sulphate reducing bacteria, concentrations of total SCFAs, and propionic and butyric acids and breath H2 as well as (b) a significant fall in faecal pH and breath CH4 excretion, and (c) a non-significant decrease in the counts of methanogenic bacteria. Reverse relations were roughly the same during the loperamide period including a significant rise in the counts of methanogenic bacteria and a significant fall in those of sulphate reducing bacteria. Conclusions-Transit time differences between healthy volunteers are associated with differences in H2 consuming flora and certain indices of colonic fermentation.
Considering the effects of some fermentation products on The factors affecting the composition and activities of colonic flora, and which could account for inter-individual variations, are largely unknown. The factors likely to be important include age, diet, colonic pH and microbial interactions, colonic supply, and availability of nutrients, bile acids and sulphate, and microbial adaptation to metabolise these substrates.' 2 69-11 Transit time through the gut may be expected to affect colonic flora because it influences both the amount of substrates flowing to the large bowel'2 13 and the efficiency of colonic fermentation.' 14 Consequently, the availability of substrate and energy for the colonic flora, as well as the pH of luminal contents, are changed. In addition, some data suggest that transit itself could affect the composition and activities of colonic flora. Indeed, the faecal bacterial mass is related to transit time in human subjects on identical dietary intakes.'5 16 transit time through the large bowel could impede SCFAs absorption, leading to sustained acidification of the contents, and modify colonic stirring, which has been shown to control H2 consumption.20 Conversely, slow transit time seems to be physiologically associated with methane production by slow growing MB, although findings are not consistent.2 ' 24 In normal subjects, transit time through the small intestine and whole gut varies greatly between people.25-28 For example, a threefold range in mean transit time (MTT) has been found in men consuming identical diets.'629 Individual variations in transit time could thus influence the composition and activities of colonic flora, which could account in part for its inter-subject variations. To test this hypothesis, we studied the relations between transit time, H2 consuming bacteria, and certain indices of bacterial fermentation in healthy volunteers given a constant diet. As transit may be the result rather than the cause of colonic events, we further changed this variable by pharmacological means and measured the changes in H2 consuming flora and fermentation products.
Methods

Subjects
The study was performed in eight healthy adults (three males and five females, 26 to provide sufficiently fast transit time in the control period such that it could be then changed during the loperamide treatment without distress to the participants.
Throughout the study, subjects took 30 radio-opaque pellets per day (10 per meal) as non-absorbable markers. Two marker shapes were used: small squares and circles. The type of marker was changed at the end of each three week period, so that total marker recovery during each period could be estimated. Subjects collected stools throughout the study and for one week after to assess the total recovery of ingested markers. Each stool was collected separately in a plastic bag suspended over the toilet and immediately frozen. The number of markers present in each stool was counted after radiographing. Transit measurements were done using the continuous marker technique described by Cummings et al,3' which permits continuous day by day MT measurement. Drug therapy was titrated to approximately double or halve the spontaneous transit time of subjects. Cisapride tablets (10 mg tablets) (Prepulsid, Janssen, Boulogne, France) were used to speed up transit. Initially two tablets were given (one with breakfast and the other with dinner), and the dose was increased by one tablet per day up to 60 mg/day if the desired effect was not achieved. Transit was slowed down using loperamide (2 mg tablets) (Imodium, Janssen, Boulogne, France). Initially, two tablets were used, and the dose was increased up to 10 mg/day if sufficient slowing in transit time did not occur. All adjustments were made during the first week of each period. The final daily doses of drugs were 40 mg (n=2) and 60 mg (n=6) for cisapride, and 6 mg (n= 1), 8 mg (n=4), and 10 mg (n=3) for loperamide. Stools collected from days 14 to 21 of each period were weighed, and the percentage of dry matter in stool aliquot was determined after freeze drying. MTT was calculated as the average value for the last seven days of control, cisapride, and loperamide periods.
Lactulose H2 breath tests After a standardised low residue evening meal and a 12 hour fast, subjects ingested 10 g lactulose (Duphalac, Duphar, Villeurbanne, France) alone or with the drug (cisapride or loperamide) on the last day of each three week period. After a thorough mouth rinse with a 1% chlorhexidine solution (Givalex, Norgan Laboratoires, Paris, France), three basal samples of end expiratory air were collected before lactulose ingestion. Further samples were taken every 10 minutes during the first two hours and every 15 minutes thereafter for eight hours. During the tests, smoking and eating were not permitted, and the subjects were non-ambulant. H2 and methane concentrations in breath samples were determined simultaneously using a Quintron model DP instrument (Quintron Microlyser, Milwaukee, WI, USA) and expressed as parts per million (1 ppm= approximately 0.05 pmol/l).
Analytical methods Freshly voided stool obtained from days 18 to 21 of each period were immediately refrigerated at 4°C under anaerobic conditions (Anaerocults A; Merck, Darmstadt, Germany) for no longer than two hours before processing. Stools were homogenised and diluted in anaerobic solution (containing (g/l): NaCl, 5; glucose, 2; cysteine. HCI, 0.3 and 5% minerals, 0.5% oligoelements, and 0.5% vitamins) to give a 10-fold dilution (wet weightlvolume). Faecal pH was measured using a pH meter (Micro pH 2000, Crison, Paris, France), and serial 10-fold dilutions were made.
Total anaerobes were measured in WilkinsChalgren agar (Difco Laboratories, Detroit MI, USA). For this purpose 1 ml of each 10-fold dilution was inoculated into 13 ml Wilkins-Chalgren agar at 45°C. Innoculated medium was then poured into 8X400 mm tubes (in duplicate), which were immediately cooled to ensure prompt solidification. 32 Total SRB were counted similarly in the medium of Pfenning et al. 33 Lactate was used as a substrate for dissimilatory sulphate reduction as it serves as a substrate to the major SRB population of the human large intestine' and that all species characterised to date utilise H2 as electron donor. 34 Total MB were measured by most probable number estimation in Balch 1 broth.35 Triplicate 10-fold dilution series were prepared in the anaerobic chamber using the anaerobic solution described above (9 ml in 30 ml vials) and incubated for each dilution between 10-2 and 10-11. The gas phase of each vial was pressurised weekly at 202 kPa using H2/C02 (4:1). Headspace gas samples were removed after 15 days to measure methane concentrations by gas chromatography (N 200, Delsi Nermag Instrument, Argenteuil, France). Vials with methane concentrations above 200 ppm were considered positive.36 Positive responses at each dilution level were counted, and the most probable numbers calculated.
For the last two subjects studied (one methane+ and one methane-), acetogenic bacteria were measured by most probable number estimation in AC-1 1 broth as described by Greening and Leedle.37 Triplicate 10-fold dilution series were prepared in the anaerobic chamber using the same anaerobic solution (9 ml in 30 ml vials) and incubated for each dilution between 10-1 and 10-1 l. The gas phase of each vial was pressurised weekly at 202 kPa using H2/C02 (4:1). For each dilution between 10-1 and 10-l, two control vials were prepared and pressurised weekly at 151.5 kPa using N2. Samples were removed after 21 days to measure acetic acid concentrations by gas chromatography (DN 200, Delsi Nermag Instrument). Vials with acetic acid concentrations above the mean of the two control vials were considered positive. 37 An aliquot of homogenised stools was mixed with a solution containing 1% (w/v) mercuric chloride and 0.61% (v/v) orthophosphoric acid in distilled water and then stored at -20°C. Thawed aliquots were centrifuged at 5000 g for 15 minutes. After addition of internal standard (4-methyl valeric acid), SCFA concentration was determined by gas chromatography (N 200, Delsi Nermag Instrument).38
Calculations and statistical analysis Mouth to caecum transit time (MCTT) was defined as the period from lactulose intake until the period just before the initial increase above fasting levels of 10 ppm or more H2 when this increase was sustained. Breath excretions of H2 and methane were estimated by integrating the area under the concentration curve (AUC) located between 0 and 600 minutes.
Stool data collected at the end of each period were expressed as daily mean (SEM). The quantitative results of bacteriological culture were expressed as the log10 of colony forming units per g wet weight faeces. One way analysis ofvariance and paired t tests were used to compare means from the three periods. Because of the curvilinear nature of curves between transit and the parameters studied, log MTT was used to calculate correlations between MTT and each parameter by simple regression. Student's unpaired t test was used to compare data between methane and nonmethane excretors.
Results
Mean transit time and stool weight Some 99 (3)% of markers ingested during the study were recovered in stools, thereby permitting accurate MT estimates.
During the control period, with similar intake of dietary fibre, MTT ranged from 41 to 122 hours and faecal output from 92 to 233 g/day (Table I ). Figure 1 shows the individual daily MTT values after marker equilibrium was reached during the control period. Although MTT variations occurred from day to day, on the whole each subject had a tendency to maintain a rather constant, either fast or slow, MTT. MTT was inversely related to stool weight and the percentage of faecal water (r=0-79, p<0.02, n=8 and r=-0.76, p<0-02, n= 8 respectively). (Fig   2) .
Over the three periods, MTT was inversely related to faecal weight (r=-0.89, p<0.001, n=24) and percentage of faecal water (r=-0.82, p<0-001, n=24). Mean transit time andfaecal bacterial counts During the control period, total viable anaerobes ranged from 10.2 to 11.5 logl/g wet weight (Table I ). In methane+, MB ranged from 8.7 to 9.8 logl/g wet weight. SRB, which were detected in all subjects, ranged from 7.3 to 9.0 logl/g wet weight. SRB counts differed significantly between methane+ and methane-(7.7 (0.2) v 8.6 (0G1) logl/g wet weight, p<005), and were negatively related to MB counts (r=-0-82, p<0.02, n=8). MTT was significantly higher in methane+ than methane-(96 (12) v 50 (8) hours, p<0.05) and was negatively related to SRB counts (r= -0.83, p<0.02, n= 8). Table II shows the changes in the counts of total viable anaerobes as well as MB and SRB induced by cisapride and loperamide administration. Total viable anaerobes were not significantly changed by drugs. Compared with the control period, the administration of loperamide induced a significant increase in MB counts (p<0 05) and a significant decrease in SRB counts (p<0005). Conversely, with cisapride MB tended to be lower (p=007), whereas SRB were significantly higher (p<0 05). In the two subjects in whom MB were below the detection level, neither MB nor SRB counts were changed by cisapride or loperamide administration. In the two subjects tested, acetogenic bacteria counts were unchanged during the three periods (Table II) .
Over the three periods, MTT correlated with MB counts (r=0.58, p=0-01, n=24) and was inversely related to SRB counts (r= -0.78, p<0-001, n=24).
Mean transit time, MCTT, H2, and methane excretion in breath after lactulose ingestion During the control period, fasting H2 concentrations were 2.7 (0.4) and 2.8 (0.6) ppm in methane+ and methane-. Fasting methane concentrations were 17 (4) ppm and 1.0 (0-1) ppm in methane+ and methane-. MTT was closely related to MCTT (r=0.97, p<0001, n= 8) and was inversely related to AUC of H2 exhaled after lactulose ingestion (r=-0-83, p<002, n=8).
Compared with the control period, cisapride administration induced a significant decrease in MCTT (97 (6) v 160 (13) minutes, p<0 05) and a significant increase in H2 excretion in breath as assessed by the AUC of H2 (p<005) (Fig 3, Table III ). In methane+, fasting methane concentration and consequently the AUC of methane were significantly reduced during cisapride administration (10 (3) v 17 (4) ppm, p<001 and 1-9 (0.2) v 3.4 (0.3) 103 ppm/min, p<005, Fig 3) . MCTT and the AUC for H2 were not significantly affected during loperamide administration (200 (24) v 160 (13) minutes, p=020 and 7.7 (0.9) v 9A4 (1-5) 103 ppm/min, p=0.30) (Fig 3,  Table III ). In methane+, fasting methane concentration and consequently the AUC of methane were significantly increased during loperamide administration (29 (2) v 17 (4) ppm, p<0-05 and 4.9 (0.5) v 3-4 (0.3) 103 ppmnmin, p<005) (Fig 3) . Interestingly, one subject (no 7) was a non-methane excretor during the control period, but became a methane excretor during loperamide administration.
Over the three periods, MTT was closely related to MCTT (r=0-74, p=0.0001, n=24) and was inversely related to the AUC of H2 (r= -062, p<0.01, n=24) (Fig 4) .
Mean transit time, faecal pH, and SCFAs During the control period, faecal pH ranged from 6.5 to 7-2 and was inversely related to MlT (r=-0-87, p<005, n=8). Compared with the control period, faecal pH was significantly reduced during cisapride administration (6&6 (0.1) v 6-9 (0-1), p<0 05) and significantly increased with loperamide (7.2 (0.1) v 6.9 (0.1), p<0001). Over the three periods, MTT was inversely related to faecal pH (r=-0.85,p<0.001, n=24).
During the control period, faecal SCFA concentration ranged from 51 to 90 mM, with mean molar proportions of 60, 17, and 13 for acetic, propionic, and butyric acids respectively (Table IV) to the concentration of total SCFAs (r= -0 70, p=005) and propionic and butyric acids concentrations (r=-0-91, p<001 and r=-0.70, p=0.05 respectively).
Compared with the control period, total SCFA concentrations, and the concentrations and percentages of propionic and butyric acid were significantly higher in the cisapride period and significantly lower in the loperamide period (Table IV) . A significant opposite variation was seen in the percentage of acetic acid, whereas its concentration remained unchanged.
Over the three periods, MTT was inversely related to the concentrations of total SCFAs (r=-0 77, p<0001). It was inversely related to the concentrations of propionic and butyric acids (r=-0.94, p<0.001 and r=-0.76, p<0001) (Fig 5) and to the percentages of propionic and butyric acids (r=-0.81, p<0Q001 and r=-0.67, p<0Q001).
Discussion
Transit changes induced by drugs in healthy volunteers given on a constant diet not only affect stool weight but also certain bacterial populations and fermentation indices. These further modifications emphasise the role oftransit in some colonic events already seen during the control period and suggest that transit time could be an important factor in the individual variability of colonic fermentations. Whether these changes in faecal flora and colonic fermentation result primarily from variations in transit or are secondary to the consequences of transit variations, basally or pharmacologically induced, needs further discussion.
Inter-individual variations in the composition and activities of colonic flora2 3 as well as variability in transit time, faecal composition, and breath excretion of gases was observed during the control period. Indeed, subjects with spontaneously fast MTT exhaled more H2 in response to lactulose. MB counts and pH were low in their faeces, whereas SRB counts and concentrations of SCFAs and propionic and butyric acids were high in their faeces. Because it may be argued that transit is the result rather than the cause of colonic events, we used the experimental protocol designed by Stephen et al '6 to demonstrate that transit influences events in the human large intestine.
Drug induced MTT changes in faecal flora did not affect the number of viable anaerobes per g of faeces, but resulted in changes in MB and SRB counts except for the two subjects in whom MB were below the detection level. Indeed, the increase in MTT with loperamide resulted in a significant fall in SRB counts and a significant rise in MB. Accordingly, breath methane was higher in the fasting state and after lactulose ingestion in methane excretors (Fig 3) . The reverse was roughly true with cisapride. The effect of loperamide was even strong enough to convert one non-methane excretor into a methane excretor. In this subject the MB count was basally higher than in other methane non-excretors, rising from 6.7 to 8.1 logl,/g wet weight during loperamide administration. Our findings are in agreement with the reported inverse relation between MB and SRB stool counts.1 44 Besides modifications in MB and SRB counts, our data show that transit modifications change the breath excretion of gases produced in the colon. However, interpretation of these data should be cautious because breath concentrations of H2 and methane are not a reliable guide of colonic production of these gases because their rate of production significantly affects their proportion exhaled in breath.47 48 In the control period as well as in the study as a whole, MIT was inversely related to the volume of H2 excreted in breath after lactulose ingestion, and this was significantly increased during cisapride administration (Fig 3) . The rise in breath H2 excretion when transit was faster cannot be explained by better diffusion from the colonic lumen towards breath gas as faster transit provides less time for colonic gas absorption and H2 is rather excreted in flatus.47 48 
